Roivant Sciences (ROIV) Common Equity (2021 - 2025)
Historic Common Equity for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to $5.0 billion.
- Roivant Sciences' Common Equity fell 1014.72% to $5.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.0 billion, marking a year-over-year decrease of 1014.72%. This contributed to the annual value of $5.2 billion for FY2025, which is 1956.0% down from last year.
- According to the latest figures from Q4 2025, Roivant Sciences' Common Equity is $5.0 billion, which was down 1014.72% from $4.8 billion recorded in Q3 2025.
- In the past 5 years, Roivant Sciences' Common Equity ranged from a high of $6.6 billion in Q4 2023 and a low of $1.3 billion during Q3 2023
- Over the past 5 years, Roivant Sciences' median Common Equity value was $2.3 billion (recorded in 2021), while the average stood at $3.5 billion.
- Per our database at Business Quant, Roivant Sciences' Common Equity tumbled by 3764.85% in 2022 and then surged by 36138.37% in 2023.
- Over the past 5 years, Roivant Sciences' Common Equity (Quarter) stood at $2.2 billion in 2021, then plummeted by 36.49% to $1.4 billion in 2022, then skyrocketed by 361.38% to $6.6 billion in 2023, then fell by 15.93% to $5.5 billion in 2024, then dropped by 10.15% to $5.0 billion in 2025.
- Its Common Equity stands at $5.0 billion for Q4 2025, versus $4.8 billion for Q3 2025 and $4.8 billion for Q2 2025.